![]() ![]() Figure 2 describes the revenue that the POCT market is anticipated to generate in 2022. Figure 1 describes the three segments that make the POCT market: Region, Product and End-user. Therefore, POCT is an important tool, which can reduce mortality, morbidity and improve the quality of life ( Lee-Lewandrowski et al., 2003 Kankaanpää et al., 2018). Quality assessment and satisfaction surveys conducted on medical staff and physicians have also shown positive affirmations toward the use of POCT. Several studies have shown that use of POCT diagnostics reduce overall per patient cost, length of stay in hospitals and provide faster results as compared to a traditional laboratory testing. POCT is shown to be of utmost importance in situations where rapid medical decisions need to be taken for example in emergency departments. Other advantages of POCT include - (a.) Simple to operate (b.) No need for trained professionals (c.) Cost-effective (d.) Easy to fabricate in bulk (e.) Rapid turn-around-time ( Luppa et al., 2011). Over the last decade, POCT has been widely accepted as a rapid and an economical form of diagnostic tool as compared to traditional laboratory-based testing especially in low resource settings ( Pai et al., 2012). “Point-of-care testing” (POCT) - Tests at or near the patient site was a term introduced in early 1980's but such a system was first developed in 1972 ( Gerald et al., 2014). Innovation in technology and emerging at-home diagnostic tests have played an important role in early disease detection, diagnosis and maintenance. ![]() Apart from this, we also delve into other microfluidic-based diagnostics that currently dominate the in-vitro diagnostic (IVD) market, current testing landscape for COVID-19 and prospects of microfluidics in next generation diagnostics. This review presents an overview of two technologies - (a.) Lateral Flow Assay (LFA) and (b.) Nucleic Acid Amplification - upon which a large chunk of microfluidic POCT diagnostics is based, some of their applications, and commercially available products. Integrating microfluidics in POCT allows fluid manipulation and detection in a singular device with minimal sample requirements. Numerous point-of-care tests and diagnostic devices are available in the market including, but not limited to, glucose monitoring, pregnancy and infertility testing, infectious disease testing, cholesterol testing and cardiac markers. The importance of POCT is considerably amplified in the trying times of the COVID-19 pandemic. Point-of-care testing (POCT) allows physicians to detect and diagnose diseases at or near the patient site, faster than conventional lab-based testing. ![]() Genome Technology Center, School of Medicine, Stanford University, Palo Alto, CA, United States. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |